Today, as you’re reading this week’s BioLinks, we’re connecting our members with the skilled talent that helps us build on excellence in the province. This morning I will have welcomed more than 600 delegates to BC's largest STEM career networking event, our annual Career Connect Day presented by BioTalent Canada. Many thanks to the sponsors, exhibitors, and companies that make this event possible.
According to the US Bureau of Labor Statistics, STEM job rate growth is projected to exceed other employment between 2022 and 2030. Our sector is the fastest growing sector in BC, and we’re home to the fastest growing life sciences sector in Canada. In the US, STEM jobs already offer double the median wage and we’re seeing higher than average wages here too in our province (source: Life Sciences in BC: Sector Profile, cowritten with the Province of British Columbia and Global Affairs Canada). We have a lot to offer, and I'm thrilled that Life Sciences BC plays such a strong role in supporting our vibrant and growing life sciences sector. I look forward to welcoming job seekers as they build their life science careers in BC.
In addition to skilled talent, investment is also a key factor driving BC life sciences success. The call for applications to our Invest in the West presented by Amplitude Ventures investor summit is now open. Companies in BC, Alberta, Saskatchewan, Manitoba, Yukon and Northwest Territories are invited to apply to pitch in the following sectors: Digital Health, Medical Devices, Medical Technology, Diagnostics, and Biotechnology. The call closes on February 1 and you can apply here.
I’m always on the lookout for ways for life science companies to grow and thrive, so I am pleased to share the following opportunity with you.
And I always enjoy celebrating success; congratulations to Caitlin Webster, who has been promoted to Director, Talent Development at AbCellera. Congratulations also to our member, Vancouver Coastal Health Research Institute, recognized recently as one of Canada’s top hospital-based research facilities. Another LSBC member, Precision Nanosystems is also poised for recognition; listed in the Medicine Maker Innovation Awards 2021 your votes could help the company win the best innovation of 2021. Results will be revealed in the April 2022 issue of The Medicine Maker.
Next week, please join us for the upcoming McCarthy Spotlight Speaking Series, taking place on January 27 from 3 to 4 PM PT. You can register here. Focused on oncology, our expert panel of speakers are presenting from a diverse background of experiences in the subject area, including imaging, assay and liquid biopsy detection strategies, therapeutic innovation, and product development. And don’t forget to add our upcoming Access To Innovation conference to your schedule; it’s a great opportunity to learn from industry leaders and we have a great line up of speakers for you.
Note: I’ve learned recently that some of you may have received an email from a direct marketing company, offering to sell a directory of professional contacts provided by or in some way associated with Life Sciences BC. Please be reassured that Life Sciences BC does not work with this company and it is not affiliated with us. Furthermore, we value our professional relationships with members and business contacts and would never sell any of our contacts lists.
Wendy and the LSBC Team
|
|
|
|
Pfizer Canada announced that Health Canada has authorized the use of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets) for the treatment of mild-to-moderate COVID-19 in adults (18 years of age and older) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death...
|
|
|
|
Pfizer will add a production facility for its antiviral COVID-19 pill in France as part of a plan to invest 520 million euros ($594 million) in the country over the next five years, the U.S. drugmaker said on Monday... Read More
|
|
|
|
Merck and Ridgeback Biotherapeutics announced the signing of a long-term supply agreement with UNICEF to facilitate broad global access for molnupiravir, an investigational oral antiviral COVID-19 medicine... Read More
|
|
|
|
Taking brain research in promising new directions is at the heart of a new Simon Fraser University (SFU) research institute, to be led by renowned neuroscientist Randy McIntosh... Read More
|
|
|
|
Edmonton-based artificial intelligence (AI) company AltaML and Montréal health-focused Amplitude Ventures want to fuel more Canadian AI and biotech companies. The two organizations have penned what they call a “strategic alliance” to source investments as well as projects where they can work together... Read More
|
|
|
|
ESSA Pharma Inc. announced the first patient dosed in the Company-sponsored Phase 1/2 study to evaluate the safety, tolerability and preliminary efficacy of ESSA’s lead product candidate, EPI-7386, a first-in-class N-terminal domain androgen receptor inhibitor, in combination with Astellas Pharma Inc.’s and Pfizer Inc.’s ligand-binding domain androgen receptor inhibitor, enzalutamide, in patients with metastatic castration-resistant prostate cancer (“mCRPC”)... Read More
|
|
|
|
InMed Pharmaceuticals Inc., a leader in the research, development, manufacturing and commercialization of rare cannabinoids, announced it has launched B2B sales of the rare cannabinoid cannabicitran (CBT) into the health and wellness sector... Read More
|
|
|
|
GlaxoSmithKline plc (GSK) announced the appointment of Tony Wood as Chief Scientific Officer designate. Tony will assume full accountability for Research and Development from current CSO, Dr Hal Barron, on 1 August 2022, after which Hal will remain on GSK’s Board and become a Non-Executive Director, with additional responsibilities to support R&D. Read More
|
|
|
|
Acuitas Therapeutics announced a multi-year sponsorship
agreement with Vancouver Athletic Football Club. This sponsorship will allow the club to expand their training resources and offset costs for equipment and uniforms, Dr. Thomas Madden, President & CEO of Acuitas recently announced... Read More
|
|
|
|
Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a collaboration agreement on custom media formulation and fulfillment solutions for the cell and gene therapy industry... Read More
|
|
|
|
Applications are now open for entrepreneurship@UBC’s Spring 2022 Venture Founder, Lab2Launch cohort!Lab2Launch is designed for UBC researchers and scientists who are focusing on the commercialization of a scientific or technological innovation which is unique and proprietary... READ MORE
|
|
|
|
Skyrocketing COVID-19 cases due to the highly contagious omicron variant have many experts talking about yearly boosters or variant-specific vaccines. But what if there were an adaptable, universal coronavirus vaccine that could fight any COVID variant or even any future coronavirus? That’s exactly what the US Army is developing right now... READ MORE
|
|
|
|
On December 3, 2021, British Columbia joined the Economic Mobility Pathways Pilot (EMPP) as a provincial partner with Immigration, Refugees and Citizenship Canada to allow skilled refugees to immigrate under the BC Provincial Nominee Program... READ MORE
|
|
|
|
Takeda Canada Inc. is pleased to announce the launch of the Takeda Canada Innovation Challenge, an initiative that aims to discover new and breakthrough digital technologies and artificial intelligence (AI) solutions that support enhanced patient care... READ MORE
|
|
|
|
A skilled talent gap is looming. Life Sciences BC is supporting and accelerating the growth of BC’s growing life sciences sector through connecting skilled talent with new opportunities through the third annual Career Connect Day presented by BioTalent Canada, taking place virtually on Friday, January 21, 2022... READ MORE
|
|
 |
ISCT is the global steward fostering cell and gene therapy translation to the clinic. With a network of leading clinicians, regulators, researchers, technologists and industry partners, ISCT members have a shared vision to translate cell and gene therapies into safe and effective therapies to improve patients’ lives worldwide.
|
|
|
|
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a patented capacitively coupled plasma emission technology.
|
|
|
|
Immunization Coordinator – Biologics Discovery
Amgen British Columbia is seeking an Immunization Coordinator – Biologics Discovery who will join the Antibody Repertoire Engineering and Screening team and contribute to the organization, initiation and assessment of immunization programs supporting antibody discovery projects.
|
|
Manager/Senior Manager,
Regulatory Affairs
XenonPharma is seeking a Manager/Senior Manager, Regulatory Affairs who will be responsible for supporting regulatory activities for submissions to Health Authorities around the world for Xenon’s programs.
|
|
LSBC Job Board
Jobs posted to our Job Board automatically post out to all our social media accounts for wider sharing. Make sure you include your company name in the first line of your job ad for maximum exposure!
|
|
|
|
Post A Job on the LSBC Website! |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish. After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? Contact Peter McLoughlin - talent@lifesciencesbc.ca
|
|
|
|
|
|
|
